Accession Number: | 0001225208-23-002370 |
Date: | 2023-02-16 |
Issuer: | BOSTON SCIENTIFIC CORP (BSX) |
Original Submission Date: |
BROWN VANCE R
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH, MA 01752-1234
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-02-16 | M | 1,838 | a | $0.00 | 40,440 | direct | ||
COMMON STOCK | 2023-02-16 | F | 568 | d | $46.48 | 39,872 | direct | ||
COMMON STOCK | 2023-02-17 | M | 1,000 | a | $0.00 | 40,872 | direct | ||
COMMON STOCK | 2023-02-17 | F | 294 | d | $46.54 | 40,578 | direct | ||
COMMON STOCK | 2023-02-18 | M | 741 | a | $0.00 | 41,319 | direct | ||
COMMON STOCK | 2023-02-18 | F | 218 | d | $46.54 | 41,101 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2023-02-16 | deemed execution date | M | 1,838 (d) | 2026-02-16 | common stock 1,838 | $0.00 | 5,516 | direct | ||
RESTRICTED STOCK UNITS | 0.0 | 2023-02-17 | deemed execution date | M | 1,000 (d) | 2025-02-17 | common stock 1,000 | $0.00 | 2,000 | direct | ||
DEFERRED STOCK UNITS | 0.0 | 2023-02-18 | deemed execution date | M | 741 (d) | 2024-02-18 | common stock 741 | $0.00 | 741 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents the company's commitment to issue one share of boston scientific common stock. |
f2 | each deferred stock unit represents the company's commitment to issue on share of boston scientific common stock. |
f3 | shares of common stock will be issued to the reporting person in four equal annual installments beginning on february 16, 2023, the first anniversary of the date of grant. |
f4 | shares of common stock will be issued to the reporting person in four equal annual installments beginning on february 17, 2022, the first anniversary of the date of grant. |
f5 | shares of common stock will be issued to the reporting person in four equal annual installments beginning on february 18, 2021, the first anniversary of the date of grant. |